Phase I trial of IACS-010759 (IACS), a potent, selective inhibitor of complex I of the mitochondrial electron transport chain, in patients (pts) with advanced solid tumors.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Timothy A Yap, Jordi Rodon Ahnert, Sarina Anne Piha-Paul, Siqing Fu, Filip Janku, Daniel D. Karp, Aung Naing, Ecaterina Elena Ileana Dumbrava, Shubham Pant, Vivek Subbiah, Apostolia Maria Tsimberidou, David S. Hong, Kelsey Meagan Rose, Quanyun Xu, Christopher P. Vellano, Mikhila Mahendra, Philip Jones, Maria Emilia Di Francesco, Joseph R. Marszalek, Funda Meric-Bernstam
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2947473258